Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teru Hideshima

Showing results (1-10 of 300) with videos related to

Pageof 30
Sort By:
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 23, 2006
[Proteasome inhibitor bortezomib as an anticancer drug]Hiroshi Yasui, Teru Hideshima
Nature Reviews. Cancer|December 3, 2002
Molecular mechanisms of novel therapeutic approaches for multiple myelomaTeru Hideshima, Kenneth C Anderson
International Journal of Hematology|September 2, 2011
Novel therapies in MM: from the aspect of preclinical studiesTeru Hideshima, Kenneth C Anderson
International Journal of Hematology|March 12, 2013
Histone deacetylase inhibitors in the treatment for multiple myelomaTeru Hideshima, Kenneth C Anderson
Seminars in Hematology|June 26, 2012
Biologic impact of proteasome inhibition in multiple myeloma cells--from the aspects of preclinical studiesTeru Hideshima, Kenneth C Anderson
Cancers|January 13, 2021
Signaling Pathway Mediating Myeloma Cell Growth and SurvivalTeru Hideshima, Kenneth C Anderson
Hematology/Oncology Clinics of North America|November 13, 2007
Preclinical studies of novel targeted therapiesTeru Hideshima, Kenneth C Anderson
Annual Review of Medicine|January 31, 2002
Thalidomide: emerging role in cancer medicinePaul Richardson, Teru Hideshima, Kenneth Anderson
Current Treatment Options in Oncology|April 30, 2004
An update of novel therapeutic approaches for multiple myelomaPaul Richardson, Teru Hideshima, Kenneth C Anderson
Experimental Hematology|September 1, 2021
Corrigendum to <'Novel therapeutic strategies for multiple myeloma'> <[Experimental Hematology 2015; 43: 732-741]>Naoya Mimura, Teru Hideshima, Kenneth C Anderson
Pageof 30

Showing results (1-10 of 300) with videos related to

Sort By:
Pageof 30
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|August 23, 2006
[Proteasome inhibitor bortezomib as an anticancer drug]Hiroshi Yasui, Teru Hideshima
Nature Reviews. Cancer|December 3, 2002
Molecular mechanisms of novel therapeutic approaches for multiple myelomaTeru Hideshima, Kenneth C Anderson
International Journal of Hematology|September 2, 2011
Novel therapies in MM: from the aspect of preclinical studiesTeru Hideshima, Kenneth C Anderson
International Journal of Hematology|March 12, 2013
Histone deacetylase inhibitors in the treatment for multiple myelomaTeru Hideshima, Kenneth C Anderson
Seminars in Hematology|June 26, 2012
Biologic impact of proteasome inhibition in multiple myeloma cells--from the aspects of preclinical studiesTeru Hideshima, Kenneth C Anderson
Cancers|January 13, 2021
Signaling Pathway Mediating Myeloma Cell Growth and SurvivalTeru Hideshima, Kenneth C Anderson
Hematology/Oncology Clinics of North America|November 13, 2007
Preclinical studies of novel targeted therapiesTeru Hideshima, Kenneth C Anderson
Annual Review of Medicine|January 31, 2002
Thalidomide: emerging role in cancer medicinePaul Richardson, Teru Hideshima, Kenneth Anderson
Current Treatment Options in Oncology|April 30, 2004
An update of novel therapeutic approaches for multiple myelomaPaul Richardson, Teru Hideshima, Kenneth C Anderson
Experimental Hematology|September 1, 2021
Corrigendum to <'Novel therapeutic strategies for multiple myeloma'> <[Experimental Hematology 2015; 43: 732-741]>Naoya Mimura, Teru Hideshima, Kenneth C Anderson
Pageof 30